On Molecular Classification of Bladder Cancer: Out of One, Many

Slides:

Advertisements

Similar presentations

Pathology 430/827 Bladder cancer Etiology, classification, and diversity David M. Berman, MD, PhD Pathology and Molecular Medicine Queen’s Cancer Research.

Advertisements

Infiltration of CD3+ and CD68+ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors1 Gottfrid.

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Figure 1 Number of somatic mutation rates across The Cancer Genome Atlas (TCGA) projects Figure 1 | Number of somatic mutation rates across The Cancer.

Volume 63, Issue 5, Pages (May 2013)

Global Trends in Testicular Cancer Incidence and Mortality

CD47 expression for in situ and invasive cutaneous epithelial lesions

Management of Muscle-Invasive Urothelial Cancer and the Emerging Role of Immunotherapy in Advanced Urothelial Cancer Karthik V. Giridhar, MD, Manish.

Cancer: Inappropriate Expression of Stem Cell Programs?

Volume 61, Issue 5, Pages (May 2012)

Volume 51, Issue 1, Pages (January 2007)

Nat. Rev. Urol. doi: /nrurol

Volume 59, Issue 1, Pages (January 2011)

Volume 71, Issue 6, Pages e171-e172 (June 2017)

Let the Games Begin (with EAU Approval)

Prostate Cancer Epidemic in Sight?

Volume 68, Issue 5, Pages (November 2015)

Volume 72, Issue 4, Pages (October 2017)

Volume 63, Issue 4, Pages e53-e56 (April 2013)

Cholinergic Innervation and Muscarinic Receptors in the Human Prostate

Bladder Cancer: A Major Public Health Issue

The Global Risk of Bladder Cancer: Let's Just Do Something About It!

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey John B. McKinlay, Carol L. Link European.

A Stepping Stone Toward Personalized Oncology: Genomic Analysis of Circulating Tumor Cells to Guide Management of Metastatic Castration-resistant Prostate.

Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma Jun Wang, MD, PhD, Zhi Li, MD, PhD,

Intraductal Carcinoma of the Prostate: Anonymous to Ominous

Prostate Cancer Detection: A View of the Future

Re: David J. McConkey, Woonyoung Choi, Colin P. N. Dinney

P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes European Urology

Volume 63, Issue 5, Pages (May 2013)

On the Origin of Syn- and Metachronous Urothelial Carcinomas

Volume 69, Issue 3, Pages (March 2016)

Volume 60, Issue 5, Pages (November 2011)

Shaheen Alanee, Kasmintan Schrader, Kenneth Offit European Urology

Volume 57, Issue 4, Pages e41-e42 (April 2010)

International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia Brett Delahunt, John R. Srigley, Lars Egevad,

The Mutational Landscape of Prostate Cancer

Prostate Cancer Epidemic in Sight?

James N. Armitage, Stuart O. Irving, Neil A. Burgess European Urology

Human Papilloma Virus, Histopathological, and Molecular Subtyping in Penile Cancer: Relevance for Prognosis and Therapy Kerstin Junker, Sebastian Hölters,

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Re: Yves Allorya, Willemien Beukers, Ana Sagrera, et al

Volume 66, Issue 6, Pages (December 2014)

Mark A. Rubin, Gabriele Girelli, Francesca Demichelis European Urology

Volume 62, Issue 4, Pages (October 2012)

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 47, Issue 1, Pages (January 2005)

The Economic Costs of Overactive Bladder in Germany

Volume 50, Issue 5, Pages (November 2006)

Volume 50, Issue 3, Pages (September 2006)

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 55, Issue 3, Pages (March 2009)

Volume 23, Issue 11, Pages (June 2018)

Testicular Cancer Variations in Time and Space in Europe

Volume 4, Issue 3, Pages (August 2013)

Prognostic Impact of Comorbidity in Patients with Bladder Cancer

Sergio Bracarda European Urology Supplements

European Urology is “Your” Journal

Epidemiology of Renal Cell Carcinoma

Economic Burden of Bladder Cancer Across the European Union

Volume 143, Issue 6, (December 2010)

Prognostic Factors in Non–Muscle-Invasive Bladder Tumors

Volume 14, Issue 4, Pages (October 2008)

Joaquim Bellmunt European Urology Supplements

To Infinium, and Beyond! Cancer Cell

Volume 54, Issue 1, Pages (July 2008)

Kiran H. Lagisetty, David G. Beer, Andrew C. Chang

Volume 51, Issue 5, Pages (May 2007)

Volume 12, Issue 6, Pages (December 2007)

Presentation transcript:

On Molecular Classification of Bladder Cancer: Out of One, Many Mattias Aine, Pontus Eriksson, Fredrik Liedberg, Mattias Höglund, Gottfrid Sjödahl European Urology Volume 68, Issue 6, Pages 921-923 (December 2015) DOI: 10.1016/j.eururo.2015.07.021 Copyright © 2015 European Association of Urology Terms and Conditions

Fig. 1 (A) Schematic representation of subtype classification overlaps in the study by Aine et al [8]. For each classification system, the subtype distribution is proportional to classification results. Overlaps between classification systems have been matched to approximate classification results. Subtype colors were obtained from the respective original publications. (B) Subtype associated differentially expressed genes categorized by transcription factors, tumor markers, and actionable targets. Genom. Unst. = genomically unstable; Inf. Epi. = infiltrated epithelial; Inf. Mes. = infiltrated mesenchymal; MDA = MD Anderson Cancer Center; SCC = squamous cell carcinoma; Sc/Ne = small cell/neuroendocrine; TCGA = The Cancer Genome Atlas; TFs = transcription factors; UNC = University of North Carolina; UroA = urobasal A; UroB = urobasal B. European Urology 2015 68, 921-923DOI: (10.1016/j.eururo.2015.07.021) Copyright © 2015 European Association of Urology Terms and Conditions